Evidence map›Paper›PMID 33263511›Full record

ArticleJournal of medical microbiology2021

Frequency of and risk factors for carbapenem-resistant

Katie E Barber, Jamie L Wagner, Rachel C Larry, Kayla R Stover

Abstract read
In one paragraph

Article in Journal of medical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Challenges of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  3. Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2025
    Article
  4. Two-centers machine learning analysis for predicting acid-fast bacilli results in tuberculosis sputum tests.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  5. Article
  6. Epidemiological data on the acquisition of carbapenem-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katie E BarberDepartment of Pharmacy Practice, University of Mississippi School of Pharmacy, 2500 North State Street, Jackson, MS, USA.
Jamie L WagnerDepartment of Pharmacy Practice, University of Mississippi School of Pharmacy, 2500 North State Street, Jackson, MS, USA.
Rachel C LarryDepartment of Pharmacy Practice, University of Mississippi School of Pharmacy, 2500 North State Street, Jackson, MS, USA.
Kayla R StoverDepartment of Pharmacy Practice, University of Mississippi School of Pharmacy, 2500 North State Street, Jackson, MS, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsCase-Control StudiesDrug Resistance, BacterialEnterobacteriaceae InfectionsFemaleHumansLevofloxacinMaleMiddle AgedRetrospective StudiesRisk FactorsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsCarbapenemsLevofloxacinTrimethoprim, Sulfamethoxazole Drug CombinationCREEnterobacteriaceaeobesity

Identifiers

PMID33263511
PMCPMC8131018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.